Company
Sapience Therapeutics
Also known as Sapience Therapeutics, Inc
- Business model
- B2B
- Legal name
- Sapience Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers.
Funding snapshot
- Total raised
- $8.3MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $8M2020-06-29
Funding rounds
- Round, 2020
- $8M2020-06-29, SEC form D sold, 83 investors
- Round, 2016
- 2016-04-05
- Round, 2015
- $300K2015-12-28, SEC form D sold, 3 investors
Loading relationship preview